Safety Shot announces data analysis from recent trial at CAHS

Safety Shot announces significant new findings from a recent clinical trial conducted at The Center for Applied Health Sciences, CAHS. The double-blind, randomized, placebo-controlled study evaluated the acute impact of Safety Shot on consumer’s Blood Alcohol Content, BAC, successfully demonstrating remarkable and statistically significant results in various measures related to alcohol consumption and the subsequent rapid reduction of BAC. Key Findings: Breath Alcohol Content: Safety Shot proved to consistently lower breath alcohol content at all measured time points compared to the placebo. Blood Alcohol Content: The study found significant improvements in BAC in the area under the curve (AUC) and maximum concentration for ethanol, acetaldehyde, and aldehyde dehydrogenase levels, favoring Safety Shot. Physical Results: Trial participants reported significantly less head discomfort, reduced fatigue, increased energy levels, improvements in concentration and reduced feelings of tiredness at multiple time points throughout the study.